Most Recent

image: How to Build Bioinformatic Pipelines Using Galaxy

How to Build Bioinformatic Pipelines Using Galaxy

By | August 1, 2016

A point-and-click interface alternative to command-line tools that allows researchers to easily create, run, and troubleshoot serial sequence analyses

0 Comments

image: Screening  with CRISPR

Screening with CRISPR

By | June 1, 2016

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

1 Comment

image: Pulling It All Together

Pulling It All Together

By | April 1, 2016

Systems-biology approaches offer new strategies for finding hard-to-identify drug targets for cancer.

0 Comments

image: Cracking the Complex

Cracking the Complex

By | November 1, 2015

Using mass spec to study protein-protein interactions

0 Comments

image: Messages in the Noise

Messages in the Noise

By | August 1, 2015

After spending more than a decade developing tools to study patterns in gene sequences, bioinformaticians are now working on programs to analyze epigenomics data.

0 Comments

image: In Custody

In Custody

By | April 1, 2015

Expert tips for isolating and culturing cancer stem cells

1 Comment

image: Tailoring Your Proteome View

Tailoring Your Proteome View

By | August 1, 2014

Computational tools can streamline the development of targeted proteomics experiments.  

0 Comments

image: Bird’s-Eye Proteomics

Bird’s-Eye Proteomics

By | July 1, 2014

A guide to mass spectrometers that can handle the top-down-proteomics challenge

1 Comment

image: Moving Target

Moving Target

By | June 1, 2014

New mass spectrometry–based techniques are blurring the lines between discovery and targeted proteomics.

0 Comments

image: Capturing Cancer Cells on the Move

Capturing Cancer Cells on the Move

By | April 1, 2014

Three approaches for isolating and characterizing rare tumor cells circulating in the bloodstream

2 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech